For example, exosomes loaded with siRNAs targeting alpha-synuclein could reduce neurotoxic protein accumulation in PD, while exosomes carrying ASOs against APP mRNA could decrease amyloid-beta production in AD. This evidence concerns the gene SNCA and Alzheimer disease.